BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33070484)

  • 1. Platelets and Breast Cancer.
    Garmi N; Nasrallah S; Baram Y; Katz A; Koren A; First M; Blum A
    Isr Med Assoc J; 2020 Oct; 22(10):613-617. PubMed ID: 33070484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of thrombocytosis on clinicopathological prognostic factors and survival in patients with vulvar cancer.
    Uysal A; Gültekin E; Taner CE; Mun S; Yidirim Y
    Ginekol Pol; 2013 Jun; 84(6):450-5. PubMed ID: 24032263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer.
    Baranyai Z; Krzystanek M; Jósa V; Dede K; Agoston E; Szász AM; Sinkó D; Szarvas V; Salamon F; Eklund AC; Szállási Z; Jakab F
    Thromb Haemost; 2014 Mar; 111(3):483-90. PubMed ID: 24285160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of thrombocytosis in patients with primary lung cancer.
    Pedersen LM; Milman N
    Eur Respir J; 1996 Sep; 9(9):1826-30. PubMed ID: 8880098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic thrombocytosis in breast cancer.
    Rajkumar A; Szallasi A
    Anticancer Res; 2013 Oct; 33(10):4545-6. PubMed ID: 24123028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Blood Lymphocytes and Platelets Are Prognostic in Surgical pT1 Non-Small Cell Lung Cancer.
    Sulibhavi A; Asokan S; Miller MI; Moreira P; Daly BD; Fernando HC; Litle VR; Suzuki K
    Ann Thorac Surg; 2020 Feb; 109(2):337-342. PubMed ID: 31593659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of thrombocytosis in ovarian cancer.
    Słabuszewska-Jóźwiak A; Dmoch-Gajzlerska E; Kozakiewicz B; Jakiel G
    Ann Agric Environ Med; 2015; 22(4):731-5. PubMed ID: 26706987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma.
    Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA
    Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pretreatment thrombocytosis on survival in primary breast cancer.
    Taucher S; Salat A; Gnant M; Kwasny W; Mlineritsch B; Menzel RC; Schmid M; Smola MG; Stierer M; Tausch C; Galid A; Steger G; Jakesz R;
    Thromb Haemost; 2003 Jun; 89(6):1098-106. PubMed ID: 12783124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
    Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
    Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis.
    Lin MS; Huang JX; Zhu J; Shen HZ
    Hepatogastroenterology; 2012 Sep; 59(118):1687-90. PubMed ID: 22591645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
    Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma.
    Moschini M; Suardi N; Pellucchi F; Rocchini L; La Croce G; Capitanio U; Briganti A; Damiano R; Montorsi F; Colombo R
    Anticancer Res; 2014 Jun; 34(6):3225-30. PubMed ID: 24922698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer.
    Scholz HS; Petru E; Gücer F; Haas J; Tamussino K; Winter R
    Anticancer Res; 2000; 20(5C):3983-5. PubMed ID: 11268488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet count and breast cancer stage.
    Fahdrin A; Sampepajung E; Pieter J; Kasim F; Smaradhania N; Prihantono P; Mariana N; Sampepajung D; Faruk M
    Breast Dis; 2022; 41(1):489-493. PubMed ID: 36641658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
    Heng S; Benjapibal M
    Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombocytosis in women with vulvar carcinoma.
    Lavie O; Comerci G; Daras V; Bolger BS; Lopes A; Monaghan JM
    Gynecol Oncol; 1999 Jan; 72(1):82-6. PubMed ID: 9889035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer.
    Komura N; Mabuchi S; Yokoi E; Shimura K; Kawano M; Matsumoto Y; Kimura T
    Int J Gynecol Cancer; 2019 Jul; 29(6):1057-1063. PubMed ID: 31203199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment Elevated Platelet Count Associates with HER2 Overexpression and Prognosis in Patients with Breast Cancer.
    Gu ML; Yuan CJ; Liu XM; Zhou YC; Di SH; Sun FF; Qu QY
    Asian Pac J Cancer Prev; 2015; 16(13):5537-40. PubMed ID: 26225707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.